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SUMMARY
The incidence and severity of light leaf spot epidemics caused
by the ascomycete fungus Pyrenopeziza brassicae on UK oilseed
rape crops are increasing. The disease is currently controlled by a
combination of host resistance, cultural practices and fungicide
applications. We report decreases in sensitivity of modern UK
P. brassicae isolates to the azole (imidazole and triazole) class of
fungicides. By cloning and sequencing the P. brassicae CYP51
(PbCYP51) gene, encoding the azole target sterol 14α-
demethylase, we identified two non-synonymous mutations
encoding substitutions G460S and S508T associated with reduced
azole sensitivity. We confirmed the impact of the encoded
PbCYP51 changes on azole sensitivity and protein activity by
heterologous expression in a Saccharomyces cerevisiae mutant
YUG37:erg11 carrying a controllable promoter of native CYP51
expression. In addition, we identified insertions in the predicted
regulatory regions of PbCYP51 in isolates with reduced azole
sensitivity. The presence of these insertions was associated with
enhanced transcription of PbCYP51 in response to subinhibitory
concentrations of the azole fungicide tebuconazole. Genetic analy-
sis of in vitro crosses of sensitive and resistant isolates confirmed
the impact of PbCYP51 alterations in coding and regulatory
sequences on a reduced sensitivity phenotype, as well as identi-
fying a second major gene at another locus contributing to resist-
ance in some isolates. The least sensitive field isolates carry
combinations of upstream insertions and non-synonymous muta-
tions, suggesting that PbCYP51 evolution is ongoing and the
progressive decline in azole sensitivity of UK P. brassicae popula-
tions will continue. The implications for the future control of light
leaf spot are discussed.
Keywords: demethylation inhibitors, fungicide resistance, light
leaf spot, P450, target site mutation.
INTRODUCTION
Pyrenopeziza brassicae B. Sutton & Rawlinson (anamorph:
Cylindrosporium concentricum Grev.) is an ascomycete fungus
causing light leaf spot on Brassica species. Historically, light leaf
spot has been problematic on oilseed rape in Scotland and north-
ern England. However, in 2012, over 92% of winter oilseed rape
crops in the UK were affected by light leaf spot in all regions
surveyed (Crop Monitor, 2012; http://www.cropmonitor.co.uk).
Disease incidence was highest in south-west England, which was
previously considered to be at lower risk than northern England
(Welham et al., 2004).The long-term (2001–2010) mean incidence
of light leaf spot in the UK was 11% of sampled plants, but, in
2012, infections were reported on 35% of plants.
The control of P. brassicae is normally reliant on a combination
of cultural practices, cultivar resistance and foliar fungicides
(Latunde-Dada et al., 2007). Boys et al. (2007) reported that the
efficacy of cultivar resistance is often reduced when varieties are
deployed on a wide scale.As oilseed rape cultivation has increased
over recent years and there are no cultivars completely resistant to
the disease, the importance of fungicides for the control of light
leaf spot remains high. The azole (imidazole and triazole) fungi-
cides are the most effective active ingredients against light leaf
spot, although the methyl benzimidazole carbamate (MBC)
carbendazim is also widely used (Home Grown Cereals Authority
(HGCA), 2003). Previous reports have described resistance to
MBCs in P. brassicae (Sutherland et al., 1994), and recently we
have shown that the resistance-conferring β-tubulin substitutions
E198A and L240F are widespread in UK P. brassicae populations
(Carter et al., 2013). Therefore, control of this disease on oilseed
rape now relies on the effectiveness of the azole component of
fungicide sprays. Azole fungicides have been widely used to
manage fungal pathogens of both animals and plants for over
30 years (Sheehan et al., 1999). They bind to the cytochrome P450
sterol 14α-demethylase (CYP51, syn. ERG11), an essential enzyme
in the biosynthesis of sterols (Parks et al., 1995). Of the many
sterols identified in fungi, ergosterol is the most common and is*Correspondence: Email: hans.cools@syngenta.com
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required for fungal growth (Weete et al., 2010). Reduced sensitiv-
ity to azoles has been reported previously in some Scottish
P. brassicae isolates (Burnett, 2003), and there is anecdotal evi-
dence of reduced azole efficacy in other locations. The molecular
and genetic basis of reduced azole sensitivity in P. brassicae has
not been investigated previously.
Studies of filamentous fungi have reported three predominant
mechanisms of azole resistance: mutations in the CYP51 gene,
overexpression of CYP51 and enhanced fungicide efflux.
Enhanced fungicide efflux, mediated by the overexpression of
efflux pumps [e.g. adenosine triphosphate binding cassette (ABC)
transporters, major facilitator proteins], has frequently been asso-
ciated with resistance in the human pathogenic yeasts, for
example Candida albicans (Prasad et al., 1995; Sanglard et al.,
1997). In contrast, enhanced efflux has rarely been reported in
field isolates of plant-pathogenic fungi. For example, genes encod-
ing ABC transporters have been identified and their capacity to
export azoles has been shown by heterologous expression and
targeted knockout studies in Botrytis cinerea, Zymoseptoria tritici
(synonym:Mycosphaerella graminicola),Magnaporthe oryzae and
Penicillum digitatum (De Waard et al., 2006). Yet, to date, only in
B. cinerea has enhanced efflux to multiple fungicides been shown
to reduce the performance of fungicides in the field (Kretschmer
et al., 2009). Overexpression of CYP51 has been associated with
reduced azole sensitivity in the plant pathogens Sclerotinia
homoeocarpa (Hulvey et al., 2012), Z. tritici (Cools et al., 2012),
Pe. digitatum (Hamamoto et al., 2000), Monilinia fructicola (Luo
and Schnabel, 2008) and Cercospora beticola (Bolton et al., 2012;
Nikou et al., 2009). In some species, CYP51 promoter modifica-
tions have been correlated with increased CYP51 expression, sug-
gesting that these sequence changes operate as transcriptional
enhancers (Hamamoto et al., 2000; Sun et al., 2013).
In plant-pathogenic fungi, CYP51 mutations are frequently
associated with azole-resistant phenotypes. To date, these have
been best studied in the wheat pathogen Z. tritici (Cools et al.,
2010, 2011; Fraaije et al., 2007; Leroux et al., 2007; Leroux and
Walker, 2011). Common CYP51 substitutions in azole-resistant
strains of Z. tritici include V136A, Y137F, A379G, I381V, Y459D,
Y461H, Y461S, ΔY459/G460 and S524T (Cools and Fraaije, 2013).
Substitutions at equivalent residues, as well as some unique
alterations, have been identified in other plant-pathogenic fungi,
including Blumeria graminis f. sp. hordei and tritici (Wyand and
Brown, 2005), Eryisphe necator (Delye et al., 1997), Puccinia
triticina (Stammler et al., 2009) and Mycosphaerella fijiensis
(Cañas-Gutiérrez et al., 2009). Biochemical studies of CYP51 from
the human pathogen C. albicans have demonstrated substitutions
identified in clinical strains that confer reduced sensitivity to
azoles by reducing binding affinity (e.g. G464S), which may also
reduce enzyme activity (Kelly et al., 1999). More recently, expres-
sion in Saccharomyces cerevisiae has demonstrated that some
CYP51 substitutions in Z. tritici (e.g. D134G) may be compensa-
tory, enhancing the activity of proteins carrying substitutions that
alone reduce enzyme activity (Cools et al., 2011).
In this article, we report the molecular characterization of
P. brassicae isolates with reduced sensitivity to azole fungicides
using a combination of classical genetics and candidate gene
approaches. The inheritance of azole resistance is complex, con-
ferred by one or two genes, with contributions from minor loci.We
sequenced the P. brassicae CYP51 (PbCYP51) gene and identified
amino acid substitutions, G460S and S508T, correlated with
reduced azole sensitivity. Heterologous expression in S. cerevisiae
showed that these substitutions reduced fungicide sensitivity. In
addition, by sequencing upstream of the predicted PbCYP51 trans-
lation start codon, we identified sequence insertions in less sen-
sitive isolates which were associated with increased induced
PbCYP51 expression. The least-sensitive field isolates carried com-
binations of PbCYP51 upstream insertions and non-synonymous
mutations.The implications of these genetic changes for the future
evolution of azole sensitivity in UK P. brassicae populations are
discussed.
RESULTS
PbCYP51 changes are associated with decreased azole
sensitivity in P. brassicae
The ratios between the 50% effective concentration (EC50) values
of the most- and least-sensitive field isolates of P. brassicae
in vitro were approximately 57-, 102-, 119-, 277- and 34-fold
to prochloraz, flusilazole, tebuconazole, prothioconazole and
metconazole, respectively (Table S1, see Supporting Information).
Four P. brassicae isolates obtained before 1996 were significantly
more sensitive to tebuconazole (Kolmogorov–Smirnov two-sample
test, P = 0.05), metconazole (P = 0.035), flusilazole (P = 0.002),
prochloraz (P = 0.006) and prothioconazole (P = 0.004) than
isolates obtained from 2003 onwards (Table S1). There was posi-
tive cross-resistance between the five azole fungicides (Fig. S1, see
Supporting Information). Cross-resistance occurred between the
imidazole prochloraz and triazoles (prothioconazole, tebucona-
zole, metconazole, flusilazole), as well as between the triazoles.
Sequencing of PbCYP51 identified two non-synonymous muta-
tions (Table 1, Table S1), at codon position 460 (G460S) in isolates
Pb7, PbUK062 and PbUK071, and at position 508 (S508T) in
isolates BS9053 and Pb1.Predicted PbCYP51 amino acid sequences
were otherwise identical in all isolates. Subsequent screening of
the full collection of isolates by restriction fragment length poly-
morphism (RFLP) detected substitution G460S in an additional six
isolates and S508T in another three.Themean resistance factors for
isolates carrying substitution G460S alone were between 7
(prochloraz) and 12 (tebuconazole/prothioconazole). Isolates car-
rying substitution S508T alone had resistance factors between 7
(prothioconazole/prochloraz) and 17 (flusilazole) (Table 1).
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Amplification of a 663-bp region upstream of the predicted
translation start codon of PbCYP51 identified a 232-bp sequence
insertion in isolates C1E and C1D, a 151-bp insertion in isolates
WC6 and I3 and a 46-bp insertion in isolate C5A (Table S1). The
232-bp sequence insertion upstream of PbCYP51 correlated with a
mean 11-fold decrease in tebuconazole sensitivity, 29-fold reduc-
tion in prothioconazole sensitivity, 13-fold reduction in flusilazole
sensitivity, eight-fold reduction in metconazole sensitivity and
eight-fold reduction in prochloraz sensitivity (Table 1), and a
decrease in sensitivity to the unrelated fungicide cycloheximide
(data not shown). Isolates with the 46- and 150-bp insertions in
PbCYP51 also showed reduced sensitivity to all the azoles tested
(Tables 1 and S1). Isolate I3, with both the 150-bp insertion and
S508T, was the least sensitive of all isolates to all triazoles
tested (Table 1). There was no change in the cycloheximide sensi-
tivity of isolates carrying the 46- and 150-bp insertions (data not
shown).
Saccharomyces cerevisiae YUG37::erg11 transformants
expressing PbCYP51 variants are less sensitive
to azoles
To verify the effect of the identified nucleotide changes on azole
sensitivity, wild-type (WT) and mutant PbCYP51 genes were
expressed in S. cerevisiae YUG37::erg11. Transformants express-
ing WT PbCYP51 protein were able to grow on SD GAL + RAF
medium (synthetic dropout medium with galactose and raffinose)
amended with doxycycline, demonstrating that WT PbCYP51 can
complement native S. cerevisiae YUG37::erg11 CYP51 function
(Fig. 1). Transformation of S. cerevisiae YUG37::erg11 with the
constructs pYES-PbCYP51S508T and pYES-PbCYP51G460S/S508T
did not affect the capacity of PbCYP51 to complement the
orthologous gene in S. cerevisiae YUG37::erg11 (Fig. 1). However,
PbCYP51 with substitution G460S did not complement
S. cerevisiae CYP51; it was therefore not possible to determine
the effect of G460S on azole sensitivity. Sensitivity testing of
S. cerevisiae YUG37::erg11 expressing PbCYP51/S508T showed
reduced sensitivity to all azoles tested. The combination of G460S
and S508T further decreased sensitivity (Table 2). The introduction
of PbCYP51 substitutions did not affect the sensitivity to
cycloheximide (Table 2).
PbCYP51 upstream insertions are associated with
induced overexpression
The shortest of the inserts found upstream of the predicted trans-
lation start codon (46 bp) was also found within the 151- and
233-bp inserts (Fig. 2A). BLAST searches revealed no significant
sequence similarity with sequences on the National Center for
Biotechnology Information (NCBI) database (data not shown).
After 6 days of growth, in the absence of fungicide treatment and
with cultures in the linear growth phase, there were no significant
differences between PbCYP51 expression of the calibrator isolate
E2C and isolates E2D, PbUK073,WC6 and C1E (Fig. 2B). There was
a six-fold increase in constitutive PbCYP51 expression in isolate
C5A. Treatment with tebuconazole increased the quantity of
PbCYP51 transcripts in all isolates. In isolates with upstream
inserts (WC6, C1E and C5A), the ratio between PbCYP51 transcrip-
Table 1 Azole sensitivities of Pyrenopeziza brassicae isolates carrying particular PbCYP51 variants.
PbCYP51 variant
Fungicide
Tebuconazole Metconazole Flusilazole Prothioconazole Prochloraz
Mean EC50
(Range)
(μg/mL) RF*
Mean EC50
(Range)
(μg/mL) RF
Mean EC50
(Range)
(μg/mL) RF
Mean EC50
(Range)
(μg/mL) RF
Mean EC50
(Range)
(μg/mL) RF
Wild-type
(n† = 14)
0.04
(0.01–0.15)
1 0.02
(0.004–0.09)
1 0.07
(0.01–0.20)
1 0.14
(0.02–0.79)
1 0.03
(0.01–0.08)
1
G460S
(n = 8)
0.49
(0.23–0.79)
12 0.15
(0.10–0.22)
8 0.68
(0.22–2.09)
10 1.63
(0.38–3.00)
12 0.20
(0.87–0.31)
7
S508T
(n = 4)
0.33
(0.28–0.49)
8 0.16
(0.11–0.20)
8 1.12
(0.56–2.00)
16 0.93
(0.30–3.02)
7 0.22
(0.18–0.33)
7
46-bp insert
(n = 1)
0.40 10 0.15 8 1.14 16 3.17 22 0.31 10
151-bp insert
(n = 1)
0.57 14 0.27 14 1.59 23 3.77 27 0.36 12
232-bp insert
(n = 3)
0.44
(0.39–0.49)
11 0.16
(0.14–0.19)
8 0.91
(0.79–1.10)
13 4.04
(3.40–4.50)
29 0.24
(0.12–0.55)
8
S508T/151-bp insert
(n = 1)
1.21 30 0.34 17 3.10 44 5.55 39 0.41 14
*Resistance factors (RF) were calculated as the ratio of the EC50 to the mean EC50 values of isolates obtained between 1993 and 1995. Mean EC50 values were calculated
on a logarithmic scale and back-transformed.
†Number of isolates with the CYP51 variant tested.
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tion with and without azole induction was 4–50-fold higher than
the ratio in isolates without the insert (E2C, E2D, PbUK073).
Genetic control of reduced azole sensitivity in
P. brassicae differs between isolates
Ascospore progeny were obtained from eight crosses between
P. brassicae isolates with different PbCYP51 alleles and/or
tebuconazole sensitivities (Table S3, see Supporting Information).
Cumulative probability distributions for observed and expected
progeny log EC50 values were generated for four crosses
(Fig. 3A,C,E,G) and the progeny genotypes at PbCYP51 were
determined (Fig. 3B,D,F,H). The tebuconazole sensitivities of
progeny from cross PbFr054 (WT) × C1E (232-bp insert) did
not follow a bimodal distribution. There was evidence for the
Fig. 1 Complementation of Saccharomyces
cerevisiae strain YUG37:erg11 with wild-type
(Pb51wt) and mutated variants of the
Pyrenopeziza brassicae CYP51 gene. Growth in
the absence (–DOX) and presence (+DOX) of
doxycycline. Bar indicates five, five-fold
dilutions of cell suspensions starting at 1 ×
106 cells/mL.
Table 2 Azole sensitivities of Saccharomyces cerevisiae YUG37::erg11 transformants.
Transformant
Introduced amino
acid substitution(s)
Tebuconazole Metconazole Prochloraz Prothioconazole Flusilazole Cycloheximide
EC50*
(μg/mL) RF†
EC50
(μg/mL) RF
EC50
(μg/mL) RF
EC50
(μg/mL) RF
EC50
(μg/mL) RF
EC50
(μg/mL) RF
YUG37::erg11_Pb51wt None 0.005 1 0.001 1 0.003 1 0.018 1 0.005 1 0.046 1
YUG37::erg11_Pb51S508T S508T 0.036 8 0.007 7 0.018 6 0.067 4 0.061 11 0.071 2
YUG37::erg11_Pb51G460S/S508T G460S and S508T 0.16 35 0.028 26 0.034 12 0.15 9 0.11 21 0.056 1
Least significant ratio‡ 2.1 4.5 12.5 1.1 4.0 1.7
*EC50 values are means of results from two independent replicates calculated on a logarithmic scale and back-transformed.
†Resistance factors (RF) were calculated as the ratio of EC50 to the EC50 of transformants expressing wild-type PbCYP51.
‡Back-transformed values differing by a ratio greater than this are significantly different at P = 0.05.
Fig. 2 (A) Schematic diagram of PbCYP51 upstream insertions. UF indicates the position of primer CYP51upstreamF and UR indicates the position of primer
CYP51upstreamR. Underlining indicates the location of the 46-bp duplicated sequence within the 151 and 233-bp inserts. Arrow indicates translation start site. (B)
Expression of PbCYP51 in Pyrenopeziza brassicae isolates measured as the mean relative quantity compared with the sample E2C (untreated). Error bars denote
95% confidence level. PbCYP51 genotypes are given in parentheses.
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Fig. 3 (A, C, E, G) Probability distributions of observed 50% effective concentrations (EC50) to tebuconazole against expected distributions based on the differences
being caused by one, two or three genes of equal additive effect. (B, D, F, H) Distribution of parental alleles in relation to EC50. Crosses are: (A, B) PbFr054 × C1E
[single-gene hypothesis (Kolmogorov–Smirnoff one-sample test, D = 0.33, P < 0.01), two-gene hypothesis (D = 0.13, P > 0.2) and three-gene hypothesis (D =
0.11, P > 0.2)]; (C, D) PbFr054 × I3 [single-gene hypothesis (Kolmogorov–Smirnoff one-sample test, D = 0.15, P > 0.2), two-gene hypothesis (D = 0.21, P > 0.1)
and three-gene hypothesis (D = 0.21, P > 0.1)]; (E, F) E2D × PbUK062 [single-gene hypothesis (Kolmogorov–Smirnoff one-sample test, D = 0.18, P > 0.2),
two-gene hypothesis (D = 0.15, P > 0.2) and three-gene hypothesis (D = 0.19, P > 0.15); (G, H) E2A × PbUK071 [single-gene hypothesis (Kolmogorov–Smirnoff
one-sample test, D = 0.42, P < 0.05), two-gene hypothesis (D = 0.2, P > 0.05) and three-gene hypothesis (D = 0.14, P > 0.2)]. The most parsimonious inference is
underlined. *indicates significant difference between observed and expected distributions. Data are adjusted means from two independent replicates. Parental EC50
was determined in the same experiments as the progeny. Error bar denotes two estimated standard errors of an isolate mean, representing approximate 95%
confidence limits for a single isolate.
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segregation of a second unlinked major gene conferring reduced
sensitivity (Fig. 3A).The 232-bp PbCYP51 upstream insert partially,
but not fully, co-segregated with reduced tebuconazole sensitivity,
with three individuals carrying this insert categorized within the
sensitive phenotypes (Fig. 3B). Both features of the data suggest
that an additional gene contributes to reduced azole sensitivity in
C1E. Cumulative probability distributions of the cross between
C1E and E2C (data not shown) supported this finding. The pheno-
type distribution and genotype segregation of progeny from the
crosses between PbUK062 (G460S) and E2D (WT) (Fig. 3E,F) and
between PbFr054 (WT) and I3 (150 bp + S508T) (Fig. 3C,D) were
consistent with single major genes accounting for the difference
between the isolates. All progeny with EC50 values greater than
0.5 μg/mL had both the PbCYP51 upstream insert and the amino
acid change S508T (Fig. 3D). In progeny labelled as ‘mixture’, both
WT and mutant PbCYP51 promoter sequences were detected,
suggesting mixed isolate cultures (Fig. 3D). Progeny from cross
E2D (WT) × PbUK062 (G460S) also followed a bimodal sensitivity
distribution (Fig. 3E), with G460S only detected in less sensitive
progeny (Fig. 3F). Therefore, a single major gene difference
accounts for the reduced sensitivity to azoles in P. brassicae iso-
lates PbUK062 and I3. In contrast, there was evidence that two
major loci contribute to differences in azole sensitivity between
isolates PbUK071 (G460S) and E2A (Fig. 3G).
DISCUSSION
Azole fungicides currently offer satisfactory control of P. brassicae
in the field. However, there have been reports of a decline in their
effectiveness (Burnett, 2003). In this study, we report modifica-
tions in the coding and predicted regulatory regions of the
PbCYP51 gene of modern P. brassicae isolates with reduced azole
sensitivity, and show that changes in other (unknown) genes can
contribute to decreases in sensitivity. The accumulation of these
changes in a single isolate is associated with the greatest reduc-
tions in sensitivity. We propose that the increased frequency of
these variants in the UK P. brassicae populations has caused the
observed reductions in the efficacy of azole fungicides in the field.
The changes identified in PbCYP51 encode amino acid substi-
tutions G460S and S508T. Substitution S508T is equivalent to the
Z. tritici CYP51 (MgCYP51) substitution S524T which, when
expressed in S. cerevisiae strain YUG37::erg11, also confers
reduced sensitivity to all azoles (Cools et al., 2011). In Z. tritici,
S524T is only found in combination with other MgCYP51 changes,
but, in P. brassicae, S508T was found alone. PbCYP51 substitution
G460S was also associated with reduced azole sensitivity in
P. brassicae. However, variants with this substitution alone did not
complement S. cerevisiae strain YUG37::erg11. The equivalent
substitution in C. albicans, G464S, has been repeatedly implicated
in resistance to clinical azoles (Morio et al., 2010; Sanglard et al.,
1998). In C. albicans, G464S perturbs the haem environment of
CYP51, which results in decreased binding affinity for azoles, and
also reduces enzyme activity (Kelly et al., 1999). The failure of
PbCYP51 with G460S to complement yeast CYP51 suggests
similar alterations in functionality, although it is unclear whether a
reduction in PbCYP51 activity reduces P. brassicae isolate fitness.
In C. albicans, in vitro growth was unaffected by the replacement
of WT CYP51 with a G464S variant, suggesting that this substitu-
tion incurs no substantial fitness cost (Sasse et al., 2012). The
expression of PbCYP51 with G460S/S508T combined comple-
mented yeast CYP51 and reduced the sensitivity to all azoles
tested by 9–35-fold, much more than S508T alone. Therefore,
PbCYP51 variants with multiple substitutions can cause further
reductions in azole sensitivity without reducing enzyme activity. In
Z. tritici, the accumulation of substitutions in MgCYP51 causes
stepwise reductions in azole sensitivity, with particular combina-
tions of alterations required to maintain optimum enzyme activity
(Cools and Fraaije, 2013; Cools et al., 2010, 2011; Leroux et al.,
2007). Although P. brassicae isolates with the PbCYP51 variant
G460S/S508T were not isolated in this study, the cloning and
sequencing of polymerase chain reaction (PCR) products from
P. brassicae population samples indicated that this variant was
present in P. brassicae populations (H. E. Carter et al., Rothamsted
Research, Harpenden, UK, unpublished results).
Some P. brassicae isolates (WC6, C1D, C1E and C5A) have the
same PbCYP51 coding sequence as sensitive isolates, but are up to
55-fold less sensitive to azoles. In these isolates, sequencing
upstream of the translation start site identified sequence duplica-
tions in the predicted regulatory regions of PbCYP51. We meas-
ured PbCYP51 transcription in the presence of subinhibitory
concentrations of tebuconazole in these isolates, in isolates E2C
and E2D with WT PbCYP51 and in isolate PbUK073 with substi-
tution G460S. Transcription was significantly greater in isolates
with upstream sequence insertions. Increases in expression caused
by alterations in the predicted regulatory regions of CYP51 are
most often constitutive. For example, the insertion of a recently
defined 194-bp transposable element (Sun et al., 2013) in CYP51A
(Ghosoph et al., 2007; Hamamoto et al., 2000) or CYP51B
(Sun et al., 2011) promoter is responsible for constitutive over-
expression in imazilil-resistant Pe. digitatum isolates. Luo and
Schnabel (2008) identified a 65-bp repetitive element in the
CYP51 gene of azole-resistant M. fructicola isolates which corre-
lated with an increase in constitutive expression of MfCYP51. In
Z. tritici, constitutive MgCYP51 overexpression is associated with
an insertion of a 120-bp transcriptional enhancer derived from the
5' end of a gene with unknown function on another chromosome
(Cools et al., 2012). Induced expression has been less widely
implicated in azole resistance than has increased constitutive
expression, although it has been suggested to contribute to resist-
ance in Sc. homoeocarpa (Hulvey et al., 2012) and Ce. beticola
(Bolton et al., 2012). In P. brassicae isolates (with the exception of
a slight increase in C5A), constitutive PbCYP51 expression was
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unaffected by upstream sequence insertions, whereas azole-
induced PbCYP51 expression was enhanced substantially. Induced
expression was highest in C5A, the isolate with the shortest
sequence insert. In addition, the 46-bp sequence duplicated in
isolate C5A was present in the 151- and 232-bp insertions of the
other PbCYP51-overexpressing isolates. Therefore, this 46-bp
region is sufficient to enhance the transcription of PbCYP51 on
azole treatment, suggesting that it encompasses a motif or
element responsive to sterol depletion.
Crossing experiments indicated differences in the genetics
underlying resistance in different P. brassicae isolates and showed
that loci other than PbCYP51were involved. For example, a variant
allele at a second locus further reduced azole sensitivity in isolate
PbUK071, but was absent from PbUK062.A major gene other than
PbCYP51 also reduced sensitivity to azoles in C1E; we have no
indication whether this is the same locus as in PbUK071. These
other genes could participate directly in resistance by, for example,
encoding a protein capable of exporting azole from the cell.
The reduced sensitivity of C1E to the unrelated fungicide
cycloheximide supports this suggestion (data not shown). The
resistance distributions in the offspring of the crosses were
broadly symmetrical on a logarithmic scale, which does not
suggest substantial epistasis between PbCYP51 and the other loci.
Isolate I3, which carries a combination of a 151-bp upstream
insert and substitution S508T, was the least sensitive isolate
tested. Progeny from the cross PbFr054 × I3 followed a bimodal
distribution of tebuconazole sensitivities, with the range between
that of the parental isolates, indicating that a single locus was
responsible for the difference in resistance. It would be of interest
to compare the offspring distribution of crosses between I3 and
isolates with only PbCYP51 changes and crosses between I3 and
PbUK071 or C1E, and between PbUK071 and C1E. The progeny of
crosses involving loci other than PbCYP51 would be predicted to
include phenotypes with resistance beyond the range of either
parent.
The most resistant P. brassicae isolate (I3) studied here has a
combination of CYP51 promoter insertion with target protein vari-
ation. This combination of mechanisms is consistent with the
evolution of decreased azole sensitivity in other pathogens.
Together with genetic evidence for mechanisms controlled by vari-
ation at other loci, it suggests that continued selection will be
effective in increasing resistance in populations to levels that
could hinder disease control. In some fungi (e.g. Z. tritici; Fraaije
et al., 2007), resistance to different azoles is negatively correlated,
allowing the substitution of azole fungicides or possibly the use of
mixtures to reduce the practical impact of resistance. In this study,
the strong positive cross-resistance between azoles suggests that
the use of diverse azole chemistries will not be an effective strat-
egy to maintain disease control. In the short term, molecular
diagnostics to rapidly detect resistant isolates will be useful.
However, this study indicates that light leaf spot control with azole
fungicides is likely to become difficult, and resistance breeding
and alternative management techniques should be developed for
the future control of P. brassicae.
EXPERIMENTAL PROCEDURES
Collection of P. brassicae isolates
The P. brassicae isolates used in this study are listed in Table S1. Isolates
were obtained by incubating infected Brassica species leaf material at 4 °C
for 3–4 days. Acervuli were suspended in sterile water to obtain asexual
spore suspensions. Aliquots of spore suspensions were spread onto 1%
malt extract agar (MEA; Oxoid, Basingstoke, Hampshire, UK) plates
amended with 100 mg/L penicillin and 200 mg/L streptomycin sulphate.
Plates were incubated for 2–3 weeks at 15 °C. Single spore isolates were
obtained by subculturing individual colonies onto new 1% MEA plates.
Additional isolates were obtained from the oilseed rape genetic improve-
ment network (OREGIN) isolate collection (Latunde-Dada et al., 2006)
In vitro fungicide sensitivity testing
Fungicide sensitivity assays were modified from Fraaije et al. (2007). Flat-
bottomed microtitre plates (Costar, Corning, New York, NY, USA) were
filled with aliquots of 2 × potato dextrose broth (PDB; Oxoid) amended
with decreasing concentrations of technical grade prothioconazole (120,
40, 13.33, 4.44, 1.48, 0.494, 0.165, 0.055, 0.0183, 0.006 and 0.002 μg/
mL), tebuconazole, flusilazole, metconazole (30, 10, 3.33, 1.11, 0.37, 0.12,
0.041, 0.014, 0.0046, 0.0015 and 0.00051 μg/mL) or prochloraz (2.5, 1.25,
0.625, 0.312, 0.156, 0.0782, 0.0390, 0.0195, 0.00977, 0.00488 and
0.00244 μg/mL) from stock solutions (10 mg/mL) in acetone. A 100-μL
aliquot of spore suspension (1 × 106 spores/mL) was added to each well.
Plates were incubated at 15 °C for 11 days. Fungal growth was measured
by absorbance at 630 nm using a FLUOstar OPTIMA microplate reader
(BMG Labtech, Offenburg, Germany). Fungicide sensitivities for each
isolate were calculated as 50% effective concentrations (EC50) using a
dose–response relationship (four-parameter fit).
DNA extraction and PbCYP51 sequencing
Macerated P. brassicae mycelium was added to 5-cm Petri dishes contain-
ing 5 mL of PDB. After 21 days of growth at 15 °C, mycelia were collected
by vacuum filtration, freeze–dried and ground using a FastPrep FP120
machine (Savants Instruments, Holbrook, NY, USA) at 4 m/s for 25 s. DNA
was extracted as described previously by Fraaije et al., (1999). A 314-bp
fragment of PbCYP51 was amplified from azole-sensitive isolate PbFr002
using primer pair F4/R4 (Table S2, see Supporting Information). PCR was
carried out in a Biometra T3000 thermocycler (Biotron GmbH, Göttingen,
Germany) in 30-μL reaction volumes containing 60 ng genomic fungal
template DNA, 0.5 μM of each primer, 200 μM of each deoxynucleoside
triphosphate (dNTP), 1.5 mM MgCl2, 1 × reaction buffer and 1.5 units Red
Hot DNA polymerase (ABgene, Epsom, Surrey, UK). The reaction conditions
were as follows: 98 °C initial denaturation for 30 s, 40 cycles at 98 °C for
10 s, 55 °C for 30 s and 72 °C for 1 min, with a final extension at 72 °C for
5 min. The upstream PbCYP51 sequence was amplified with the Universal
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GenomeWalker kit (Clontech, Palo Alto, CA, USA). Genomic DNA was
digested and ligated to GenomeWalker adaptors according to the man-
ufacturer’s protocol. Primary and secondary PCRs were carried out in
50-μL reaction volumes containing 2.5 units Easy-A High Fidelity PCR
Cloning Enzyme (Stratagene, La Jolla, CA, USA), 1 × Easy-A reaction buffer,
0.5 μM adapter primers (AP1/AP2, Stratagene), 0.5 μM gene-specific
primer (CYPgspUP/CYPnestedUP; Table S2), 200 μM of each dNTP and
1 μL of library DNA. The thermocycling parameters were as recommended
by the manufacturer’s protocol. The downstream PbCYP51 sequence was
amplified using primers CYPgspDOWN/CYPnestedDOWN (Table S2). PCR
was carried out using Red Hot DNA polymerase. The annealing tempera-
ture was 60 °C and the extension time was 1 min. PCR products were
visualized by separation on ethidium bromide-stained 1% (w/v) agarose
gels run in 1 × Tris-borate–ethylenediaminetetraacetic acid (EDTA) buffer,
followed by exposure to UV light. PCR products were purified using the
Wizard SV gel and PCR clean-up system (Promega, Madison, WI, USA),
according to the manufacturer’s protocol. Purified PCR products were
ligated to the pGEM-Easy vector (Promega) and transformed into JM109
high efficiency competent Escherichia coli cells (Promega). Purified
plasmid DNA was sequenced by MWG Eurofins Operon (Ebersberg,
Germany) using the primers M13uni(-21) and M13rev(-29). The complete
PbCYP51 was amplified from 17 isolates of different azole sensitivities
using PbCYP51F and PbCYP51R (Table S2). PCRs were carried out using
Phusion high-fidelity DNA polymerase in 30-μL reaction volumes. The
annealing temperature was 56 °C and the extension time was 2 min.
Purified PCR products were sequenced using CF1, CF2 and CR2 (Table S2).
Sequences were assembled and translated in Vector NTI. The predicted
protein sequences were aligned using MUSCLE (Edgar, 2004) and amino
acid substitutions were noted.
PCR-RFLP
A 1244-bp PbCYP51 fragment encompassing PbCYP51 codons 460 and
508 was amplified using CYP51expressionF1/CYP51R (Table S2). PCR was
carried out using Phusion high-fidelity DNA polymerase. The annealing
temperature was 55 °C and the extension time was 1.5 min. To detect
G460S, approximately 10 ng of PCR product were digested with 2 units of
TspRI (CASTG) and 1 × NE buffer 4 in a total volume of 10 μL at 65 °C for
2 h. For the detection of S508T, approximately 100 ng of PCR product were
digested with 1 unit of BssSI (CACGAG) and 1 × NE buffer 3 in a total
volume of 10 μL at 37 °C for 2 h. Restriction fragments were separated by
electrophoresis on 1% (w/v) agarose gels.
RNA extraction and cDNA synthesis
Total RNA was extracted from freeze–dried mycelia of P. brassicae isolates
with TRIZOL reagent (Invitrogen, Carlsbad, CA, USA) following the man-
ufacturer’s protocol. A subsequent overnight incubation of extracts in 4 M
lithium chloride was used to further purify RNA. Five micrograms of total
RNA were reverse transcribed with oligo(dT)20 using the SuperScript III
First Strand Synthesis System (Invitrogen), according to the supplier’s
instructions.
Heterologous expression of PbCYP51
The full-length coding sequence of PbCYP51 was amplified from a 1:10
dilution of synthesized cDNA from isolate E2D using primers CYP51KpnI
and CYP51EcoRI (Table S2), which incorporated KpnI and EcoRI restriction
sites, respectively, to enable cloning in yeast expression vector pYES2/CT
(Invitrogen). PCRs were carried out with EasyA High Fidelity PCR cloning
enzyme at an annealing temperature of 55 °C and an extension time of
2 min. The purified PCR product was cloned into the pGEM-Easy vector to
create pGEM-PbCYP51wt and an internal KpnI restriction site was
removed using the QuikChange II site-directed mutagenesis kit
(Stratagene), according to the supplier’s instructions. The pGEM-PbCYP51
construct was digested with KpnI and EcoRI (New England Biolabs,
Ipswich, MA, USA), and PbCYP51 was cloned into yeast expression vector
pYES2/CT, creating plasmid pYES-PbCYP51, which was transformed into
S. cerevisiae strain YUG37:erg11 (MATa ura3-52 trp1-63 LEU2::tTA tetO-
CYC1::ERG11) (Revankar et al., 2004) using the S. cerevisiae EasyComp
transformation kit (Invitrogen), according to the manufacturer’s instruc-
tions. Transformants were plated out onto SD minimal medium containing
1.6 g/L dropout medium supplement without uracil (Sigma, St Louis, MO,
USA), 2 g/L yeast nitrogen base without amino acids (Difco, Detroit, MI,
US), 2% galactose and 2% raffinose with and without 3 μg/mL
doxycycline.
Site-directed mutagenesis
The PbCYP51 substitutions G460S and S508T were introduced alone and
in combination into the pYES-PbCYP51 plasmid by site-directed
mutagenesis with primers SDMG460S and SDMS508T using the
QuikChange II site-directed mutagenesis kit. All pYES-PbCYP51 constructs
were sequenced to confirm the correct introduction of mutations and to
ensure the validity of sequences. Saccharomyces cerevisiae YUG37::ERG11
was transformed with pYES-PbCYP51 constructs and grown on SD
dropout medium as described previously.
Complementation analysis of S. cerevisiae
YUG37:erg11 transformants
Saccharomyces cerevisiae YUG37:erg11 transformants were grown in
20 mL of liquid SD medium for 24 h with shaking at 250 rpm at 30 °C. Cell
suspensions were adjusted to 1 × 106 cells/mL. Decreasing concentrations
of cell suspensions (5 μL of five five-fold dilutions) were inoculated onto
SD GAL + RAF agar plates with and without 3 μg/mL doxycycline. The
plates were incubated at 20 °C and 30 °C, and photographed after 72 h.
The pYES2/CT vector was used as a negative control.
Fungicide sensitivity testing of S. cerevisiae
YUG37:erg11 transformants
Saccharomyces cerevisiae YUG37:erg11 transformants were grown for
24 h with shaking at 250 rpm at 30 °C in 20 mL SD GAL + RAF liquid
medium. Cell concentrations were adjusted to 1 × 106 cells/mL and 100-μL
aliquots were added to wells of flat-bottomed microtitre plates. SD GAL +
RAF medium with doxycycline (6 μg/mL) was amended with 0,
2.82 × 10−5, 8.47 × 10−5, 0.000254, 0.000762, 0.00229, 0.00686, 0.0206,
0.0617, 0.185, 0.556, 1.67 or 5 μg/mL flusilazole, tebuconazole,
prothioconazole, metconazole, prochloraz and cycloheximide, and 100 μL
were added to the wells of microtitre plates. The plates were incubated for
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5 days at 20 °C. Fungicide sensitivities were determined as EC50 values
for replicate transformants, and resistance factors were calculated as the
ratio of the mean EC50 values to those of S. cerevisiae YUG37:erg11
transformants expressing WT PbCYP51.
Sequencing predicted PbCYP51 regulatory regions
Sequences immediately upstream of the predicted PbCYP51 coding
sequence were amplified using the primer pair CYP51upstreamF/
CYP51upstreamR in all P. brassicae isolates listed in Table S1 and in the
progeny of crosses PbFr054 × C1E and PbFr054 × I3. PCR was carried out
using Phusion high-fidelity DNA polymerase. The annealing temperature
was 57 °C and the extension time was 1 min. PCR products that differed
from the PCR product size of the reference isolate PbFr002 were
sequenced using CYP51upstreamR.
Quantitative reverse transcription-polymerase chain
reaction (RT-PCR)
Three-millilitre aliquots of P. brassicae spore suspensions (1 × 106 spores/
mL) were added to 6 mL of PDB in 55-mm Petri dishes. After 4 days,
tebuconazole was added to cultures at the approximate EC50 for each
isolate (0.5 μg/mL for WC6, PbUK073, C1E and C5A, and 0.05 μg/mL for
E2C and E2D). Cultures were incubated for a further 48 h before mycelia
were harvested by centrifugation at 4 °C, snap frozen in liquid nitrogen
and freeze–dried for 24 h. For each isolate, an untreated culture grown
under the same conditions was also harvested. The experiment was
repeated three times. Quantitative RT-PCRs were carried out using SYBR
Green Jumpstart Taq Ready Mix (Sigma). The 20-μL reaction mix contained
5 μL of cDNA of a 1:10 dilution, 0.25 μM of each primer and 10 μL of 2 ×
SYBR Green Jumpstart Taq Ready mix (Sigma). The thermocycling param-
eters were 95 °C for 2 min, followed by 40 cycles of 95 °C for 15 s, 60 °C
for 30 s and 72 °C for 36 s. A melt curve was performed following
thermocycling. Reactions were carried out in triplicate using the ABI 7500
real-time PCR system (Applied Biosystems, Foster City, CA, USA). The
endogenous controls were P. brassicae β-tubulin (Table S2) and
P. brassicae glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Singh,
1998). Data were analysed using the supplied 7500 SDS software. Mean
relative transcript abundances of three biological replicates were calcu-
lated relative to the untreated control (E2C) using the 2–ΔΔCt method (Livak
and Schmittgen, 2001).
Crossing of P. brassicae isolates
Mating types of P. brassicae isolates were determined using primers Mt3,
PbM-2 and PbM-1–3 (Table S2; Foster et al., 2002). PCR was carried out
using 1.25 U OneTaq DNA Polymerase (New England Biolabs), 1 × OneTaq
Standard Reaction Buffer, 200 μM each dNTP, 0.1 μM PbM-1-3 and M2,
and 0.2 μM Mt3. Thermocycling parameters were 94 °C initial denatura-
tion for 30 s, 30 cycles at 94 °C for 30 s, 56 °C for 30 s and 68 °C for 1 min,
with a final extension at 68 °C for 5 min. Sexual crosses were established
by inoculating equal volumes (40 μL) of spore suspension (1 × 106 spores/
mL) of isolates of opposite mating types onto 1% MEA plates. Plates were
incubated in the dark at 15 °C for 12–20 weeks. After apothecia had
formed, the Petri dish lids were filled with 1% MEA, the plates were
inverted and individual germinating ascospores were subcultured. To
confirm sexual recombination, progeny were genotyped using mating
type, β-tubulin and CYP51 sequence polymorphisms. Progeny were tested
for in vitro sensitivity to carbendazim as described previously. Adjusted
mean log EC50 values were determined using analysis of variance
(ANOVA). Cumulative probability distributions for observed and expected
progeny log EC50 values were generated by ranking progeny log EC50
values and dividing by the total number of observations. Expected distri-
butions under the hypotheses that one, two or three independent and
additive loci were segregating in the cross were generated using the
corresponding Mendelian expectations for segregation in haploid crosses
(1:1, 1:2:1, 1:3:3:1) and the observed standard error of the mean for an
isolate EC50. One-sample Kolmogorov–Smirnov tests were used to test the
differences between the observed and expected cumulative probability
distributions.
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